Literature DB >> 34613583

Elemental Composition of Pheochromocytoma Resolved on Solid/Adrenal Tissue and Whole Blood Level.

Jovana Jagodić1, Branislav Rovčanin2,3, Ivan Paunović2,3, Mladen Mihailović4, Nebojša Zečević2, Dragan Manojlović1,5, Aleksandar Stojsavljević6,7.   

Abstract

Pheochromocytoma (PCC) is an unusual benign adrenal tumor with an unexamined status of the elements. This study delivers the first insight into the levels of microelements (Mn, Co, Cu, Zn, As, Se, Th), toxic elements (Cd, Pb, U), and macroelements (Na, K, Mg, Ca) in both adrenal tissue and whole blood samples collected from PCC patients. The results were strengthened by comparing recorded findings with the patients' healthy adrenal tissue (HAT) and with whole blood samples from the healthy individuals. PCCs had significantly higher levels of Zn, Se, Na, K, and Mg and lower levels of Mn, Co, Pb, and As than that of HATs. Compared to healthy blood samples, the patients' blood exhibited considerably higher levels of Na, K, and Ca but significantly lower levels of Mn, Cu, Zn, Se, and Mg. Females had significantly higher levels of essential Se and toxic Pb and Cd in their PCC tissue samples compared to males. PCC tissue levels of Mn and Cu were significantly elevated in smokers over levels in nonsmokers and in PCC patients with tumor sizes below 5 cm compared to PCC diameters above 5 cm. The data presented in this study provide a new insight into the pathophysiology of PCC. Thus, recorded elements should be considered as initiators/modifiers of PCC and potential inductors of malignant transformation. The findings of this research deepen scientific understanding of this rare adrenal disease, which, in turn, could highlight the pathogenesis of PCC.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adrenal tissue; Macroelements; Microelements/trace elements; Pheochromocytoma (PCC); Whole blood

Mesh:

Substances:

Year:  2021        PMID: 34613583     DOI: 10.1007/s12011-021-02945-2

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  28 in total

1.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

2.  Pheochromocytoma - update on disease management.

Authors:  Roland Därr; Jacques W M Lenders; Lorenz C Hofbauer; Bernd Naumann; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

Review 3.  Laboratory evaluation of pheochromocytoma and paraganglioma.

Authors:  Graeme Eisenhofer; Mirko Peitzsch
Journal:  Clin Chem       Date:  2014-10-20       Impact factor: 8.327

4.  Challenges in the diagnosis of pheochromocytoma and paraganglioma syndrome.

Authors:  Aleksandra Zdrojowy-Wełna; Grazyna Bednarek-Tupikowska
Journal:  Neuro Endocrinol Lett       Date:  2014       Impact factor: 0.765

Review 5.  Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings.

Authors:  Guido Grassi; Fosca Quarti Trevano; Raffaella Dell'Oro; Gino Seravalle; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

Review 6.  Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice.

Authors:  T Zelinka; G Eisenhofer; K Pacak
Journal:  Stress       Date:  2007-06       Impact factor: 3.493

Review 7.  Pheochromocytoma: a review.

Authors:  A Tsirlin; Y Oo; R Sharma; A Kansara; A Gliwa; M A Banerji
Journal:  Maturitas       Date:  2014-01-05       Impact factor: 4.342

8.  Pheochromocytoma: a long-term follow-up of 24 patients undergoing laparoscopic adrenalectomy.

Authors:  Lísias N Castilho; Fabiano A Simoes; Andre M Santos; Tiago M Rodrigues; Carlos A dos Santos Junior
Journal:  Int Braz J Urol       Date:  2009 Jan-Feb       Impact factor: 1.541

Review 9.  Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas.

Authors:  Anouk C Meijs; Marieke Snel; Eleonora P M Corssmit
Journal:  Hormones (Athens)       Date:  2021-02-11       Impact factor: 2.885

Review 10.  Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Authors:  Rajesh V Thakker
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.